The ACCESS Model: Health Tech’s Next Gold Rush?
The video outlines a forthcoming Medicare Access Program that will allow beneficiaries and their physicians to obtain FDA‑cleared health apps and wearable devices with federal reimbursement. Unlike today’s corporate‑benefits model, providers will face a senior population with lower digital health literacy, a need for multilingual interfaces, and stricter evidence requirements from physicians and health systems. The presenter notes that companies must navigate a hybrid marketplace where both patients and doctors influence purchasing, and cites his Health Affairs Forefront article for deeper analysis. Successfully adapting could unlock a multi‑billion‑dollar revenue stream while improving chronic‑disease management for older Americans, but failure to meet these barriers could stall growth.
When Screening Guidelines Shift: Impacts on Healthcare Access & Use
The podcast examines how recent revisions to screening and treatment guidelines—particularly the ACC/AHA lipid recommendations, newer hypertension targets, and lowered colon‑cancer screening age—reshape health‑care utilization and spending. The lipid update introduces the Prevent risk equations, lowers the treatment threshold to a...
Policy Changes Reshaping Family Caregiving | Age-Friendly Health Series
The Age‑Friendly Health Series podcast examined the rapidly evolving policy environment surrounding family caregiving, featuring host Katherine Ornstein and caregiving scholar Allison Baroff. Baroff highlighted that roughly one‑quarter of Americans serve as unpaid caregivers, a role that now costs the...
How Climate Change Is Affecting Farmers’ And Ranchers’ Mental Health
The Health Affairs podcast spotlights a new issue exploring climate, health, and equity, focusing on a recent article by Ma Powell that examines how climate change is reshaping farmers’ mental health. Powell shares her personal journey from a community‑supported vegetable farm...
Health Care Workers In A Storm’s Path
An academic internal‑medicine physician and residency director recounts the chaos wrought by Hurricane Irma in September 2017 across South Florida’s low‑lying coastal region. The Category‑5 storm forced mass evacuations, with Miami‑Beach officials dubbing it a "nuclear hurricane," and left hospitals...
Prioritizing Community Health Solutions For Extreme Heat
Extreme heat poses a growing public‑health threat, especially for vulnerable Seattle‑King County residents. Researchers Sadia Hessen and Brad Kramer describe a participatory system‑science project that brings community members, agencies, and academics together to co‑design solutions. Using group model‑building workshops, participants created...
Provider Prices in the Commercial Sector: Reaching a Common Understanding
The virtual event, hosted by Health Affairs and funded by Arnold Ventures, examined how provider prices—especially hospital charges—drive commercial health‑spending growth. Data presented showed hospitals consume about 31% of total U.S. health expenditures, physician services 21%, and prescription drugs only 9%....
Why Traditional Payer-Provider Partnerships Fall Short In Specialty Care
The video argues that conventional payer‑provider partnerships are fundamentally misaligned for specialty care, where most healthcare cost growth occurs. Traditional tools—pay‑for‑performance, risk contracts, and shared‑savings—target revenue streams but leave the underlying delivery process untouched, resulting in stagnant costs and outcomes. Key...
What Drives Administrative Costs in U.S. Health Insurance?
The Health Affairs paper by Dr. Jason Bucksbomb and co‑authors provides the first systematic, state‑level comparison of health‑insurance administrative spending and profit for 2023, covering fully insured commercial plans, self‑funded commercial coverage, and Medicaid managed‑care. The authors estimate roughly $600 per enrollee...
The 340B Program: Why It Avoids Budget Scrutiny
The video examines the 340B drug pricing program, a federal initiative that requires pharmaceutical manufacturers to sell medicines to eligible hospitals at deep discounts. Originally limited to roughly 90 providers, the program now includes more than 2,600 hospitals, many of...
New Prior Authorization Proposals: Implications for Prescription Drug Access
The podcast discusses CMS’s latest proposal to extend prior‑authorization deadlines to prescription drugs, building on a 2024 rule that applied only to surgeries and services. The rule would set a one‑week response window for standard requests and three days for expedited...
Which Star Ratings Are Driving Medicare Advantage Quality Gains
The podcast discusses a new Health Affairs study examining where Medicare Advantage (MA) star‑rating quality gains have come from between 2015 and 2025. While the star system is intended to steer private plans toward better outcomes, the researchers found...
The FY 2027 HHS Budget Proposal: Changes, Cuts, and Investments
The White House unveiled its FY 2027 budget request for the Department of Health and Human Services, proposing a $111 billion discretionary allocation—12.5% lower than the FY 2026 level, roughly a $16 billion cut. The proposal signals a sharp shift toward defense spending while...
What Most Favored Nation Drug Pricing Would Mean for the US
The video examines the most‑favored‑nation (MFN) drug‑pricing proposal that would tie U.S. prices to the lowest rates paid by other developed economies. Host Dr. James Robinson explains why the idea has gained political traction, especially after President Trump’s pledge to...
2027 Medicare Advantage Final Payment Rule: Key Changes Explained | David Meyers
The Centers for Medicare & Medicaid Services (CMS) released its final payment rule for Medicare Advantage (MA) plans for the 2027 benefit year, announcing a 2.48% increase in base rates – a figure far above the modest 0.009% bump proposed...